Northern Trust Corp Amphastar Pharmaceuticals, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 594,437 shares of AMPH stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
594,437
Previous 613,170
3.06%
Holding current value
$14.6 Million
Previous $22.8 Million
24.31%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$146 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$59.6 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$54.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$39.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$33.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.2B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...